Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Dec 2024 is 14.71% vs 16.29% in Dec 2023
Consolidate Net Profit
YoY Growth in quarter ended Dec 2024 is 77.07% vs 162.06% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Dec 2024 is 48.13% vs 22.04% in Dec 2023
Interest
YoY Growth in quarter ended Dec 2024 is -25.15% vs 19.28% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023
Compare Quarterly Results Of Strides Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2024 is -1.14% vs 7.30% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 14.71% vs 16.29% in Dec 2023
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2024 is 22.42% vs 2.34% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 77.07% vs 162.06% in Dec 2023
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2024 is 13.93% vs -14.92% in Sep 2024
YoY Growth in quarter ended Dec 2024 is 48.13% vs 22.04% in Dec 2023
Quarterly - Interest
QoQ Growth in quarter ended Dec 2024 is -29.31% vs -8.17% in Sep 2024
YoY Growth in quarter ended Dec 2024 is -25.15% vs 19.28% in Dec 2023
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2024 has improved from Sep 2024
YoY Growth in quarter ended Dec 2024 has improved from Dec 2023